5th International Workshop on Microbiome in

HIV Pathogenesis, Prevention and Treatment 

Enduring Materials

We are pleased to look back on a very successful 5th International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment, held on the 16th and 17th October 2019 in Rockville, Maryland, USA.

Session 1 -  Pathogenesis

Regulation of intestinal viral infections by the microbiota

Megan Baldridge, MD, PhD - Washington University School in St. Louis, USA

Session 1 -  Abstract-driven Presentations (no video available for abstracts)

Fecal microvesicles differentially influence translocating bacterial taxa after SIV infection

Glycomic determinants of gut microbial dysbiosis and translocation during suppressed HIV infection

Leila Giron

Session 2 -  Transmission & Prevention

Multi-omic assessment of interactions between an intravaginal ring delivering TDF and FTC and the vaginal microbiome in a Phase 1 randomized, placebo-controlled clinical trial

Marc Baum, BSc, PhD - Oak Crest Institute of Science, USA

Metaproteomics to understand mucosal inflammation associated with HIV acquisition risk in young African women

Lindi Masson, MSc, PhD - University of Cape Town, South Africa

Update on live biotherapeutic trials to prevent vaginal dysbiosis and HIV

Craig Cohen, MD, MPH - University of California San Francisco, USA

Session 2 -  Abstract-driven Presentations (no video available for abstracts)

Host genetic determinants of the vaginal microbiome and bacterial vaginosis in Kenyan women

Elevated fecal inflammatory biomarkers in HIV-/+ MSM associate with gut microbiota

Jennifer Schneider

Session 3 - Comorbidities

The relationship between the gut microbiome, inflammation and metabolic disease in HIV infected and high risk populations

Endotoxemia, inflammation and HIV: Revisiting an old concept

Session 3 - Abstract-driven Presentations (no video available for abstracts)

Colonic microbiota is altered in treated HIV infection independently of sexual practice and correlates with HIV disease progression

Metformin treatment and gut microbiota in non-diabetic persons living with HIV

Stéphane Isnard

Session 4 - Vaccines

Diversion of HIV-1 vaccine-induced immunity by gp41-intestinal microbiota cross-reactive antibodies

Gut microbiome perturbation by oral antibiotics leads to vaccine hypo-responsiveness

Daria Hazuda, PhD - Merck, USA

Session 5 -  Therapeutics

Development of a live biotherapeutic product: Opportunities and challenges

Scott Plevy, MD - Synlogic, USA

Session 5 - Abstract-driven Presentations (no video available for abstracts)

Rational donor fecal microbiota transplantation in HIV (REFRESH Study)

Oral fecal microbiota transplantation increases gut microbiome diversity and alters the microbiome distribution in people with HIV

Netanya Utay

Session 6 - Women Surviving and Aging with HIV

Guaraldi, Giovanni  2017 120x160.jpg

Modena Cohort

Giovanni Guaraldi, MD - University of Modena and Reggio Emilia, Italy

Averitt, Dawn 2020 120x160.jpg

Community Perspective

Dawn Averitt - The Well Project/WRI, USA

Session 6 -  Abstract-Driven Presentations

CD4:CD8 ratio normalization among treatment naive women

Differences by gender and sexual orientation in treatment satisfaction and aspirations among persons living with HIV

Chinyere Okoli, PharmD - ViiV Healthcare, UK  

Attitudes towards health, sexual intimacy, and child-bearing among women living with HIV in 24 countries

Chinyere Okoli, PharmD - ViiV Healthcare, UK 

Gender, equality, and empowered decision-making in HIV care

Chinyere Okoli, PharmD - ViiV Healthcare, UK 

Impact of Microbial Exposures on HPV Immune Titers and Infection Among HPV-Vaccinated Women Living with HIV

Elisabeth McClymont, MD - University of British Columbia, Canada

Closing Session - Panel Discussion

Panel Discussion

Biltstraat 106

3572 BJ, Utrecht, the Netherlands

info@virology-education.com

  • White Twitter Icon
  • White LinkedIn Icon
  • White Facebook Icon

Tel: +31 (0)30 230 7140

© 2020 by Virology Education